Literature DB >> 28144008

Balloon postdilatation is a mandatory step in the deployment of bioresorbable vascular scaffold.

Ahmet Karabulut1.   

Abstract

Entities:  

Mesh:

Year:  2017        PMID: 28144008      PMCID: PMC5324868          DOI: 10.14744/AnatolJCardiol.2017.7551

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN: 2149-2263            Impact factor:   1.596


× No keyword cloud information.
To the Editor, I read the article by Özel et al. (1) entitled “What is better for predilatation in bioresorbable vascular scaffold implantation: a noncompliant or a compliant balloon?” recently published in Anatol J Cardiol 2016; 16: 244-49 with great interest. The authors demonstrated the effect of balloon predilatation using non-compliant and compliant balloon catheter in the deployment of bioresorbable vascular scaffold (BVS). They stated that balloon dilatation with noncompliant balloon may decrease the need for balloon postdilatation. Drug-eluting BVS is a milestone for percutaneous coronary intervention. Although commercial packing of BVS looks similar to metallic stent, deployment is more sophisticated and requires proper predilatation, postdilatation of the lesion, and use of ot- her imaging methods, including intravascular ultrasonography and optical coherence tomography (OCT) (2, 3). Proper apposition of scaffold is one of the major predictors of scaffold failure. Thus, routine high-pressure balloon postdilation with noncompliant balloon catheter was suggested. Since BVS struts are not visible under fluoroscopy, additional imaging techniques, especially OCT, show apposition of the scaffold more clearly and enhance success rate of the procedure (4). Özel et al. (1) also stated that choice of noncompliant balloon predilation would decrease need for postdilatation. It is significant that rate of balloon postdilatation is not high, and it was approximately 50% in the mentioned investigation. It is not advisable to state that there is advantage with noncompliant balloon predilation with respect to reducing need for postdilatation without additional intravascular imaging technique. Conventional angiographic imaging cannot accurately guide proper apposition of the scaffold. Dalos et al. (5) reported that focal radial expansion was significantly reduced in BVS compared to drug-eluting metal stent in routine clinical setting without observing routine postdilatation protocol. In conclusion, routine balloon postdilatation with non-comp- liant balloon catheter is as crucial as lesion preparation. Importance of balloon postdilatation should not be neglected by the authors, and all practitioners should be encouraged to perform routine noncompliant balloon postdilatation regardless of angiographic image to increase success rate of BVS deployment.
  5 in total

1.  Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds.

Authors:  Gianluca Caiazzo; Giovanni Longo; Alessandra Giavarini; Ismail Dogu Kilic; Enrico Fabris; Roberta Serdoz; Alessio Mattesini; Nicolas Foin; Gioel Gabrio Secco; Salvatore De Rosa; Ciro Indolfi; Carlo Di Mario
Journal:  Int J Cardiol       Date:  2016-07-05       Impact factor: 4.164

2.  Angiographic and optical coherence tomography insights into bioresorbable scaffold thrombosis: single-center experience.

Authors:  Antonios Karanasos; Nicolas Van Mieghem; Nienke van Ditzhuijzen; Cordula Felix; Joost Daemen; Anouchska Autar; Yoshinobu Onuma; Mie Kurata; Roberto Diletti; Marco Valgimigli; Floris Kauer; Heleen van Beusekom; Peter de Jaegere; Felix Zijlstra; Robert-Jan van Geuns; Evelyn Regar
Journal:  Circ Cardiovasc Interv       Date:  2015-05       Impact factor: 6.546

3.  Cutting balloon use may ease the optimal apposition of bioresorbable vascular scaffold in in-stent stenosis.

Authors:  Ahmet Karabulut; Yasemin Demirci
Journal:  Postepy Kardiol Interwencyjnej       Date:  2015-03-06       Impact factor: 1.426

4.  Mechanical properties of the everolimus-eluting bioresorbable vascular scaffold compared to the metallic everolimus-eluting stent.

Authors:  Daniel Dalos; Clemens Gangl; Christian Roth; Lisa Krenn; Sabine Scherzer; Markus Vertesich; Irene Lang; Gerald Maurer; Thomas Neunteufl; Rudolf Berger; Georg Delle-Karth
Journal:  BMC Cardiovasc Disord       Date:  2016-05-25       Impact factor: 2.298

5.  What is better for predilatation in bioresorbable vascular scaffold implantation: a non-compliant or a compliant balloon?

Authors:  Erdem Özel; Ahmet Taştan; Ali Öztürk; Emin Evren Özcan; Samet Uyar; Ömer Şenarslan
Journal:  Anatol J Cardiol       Date:  2015-06-18       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.